Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop

dc.contributor.authorOndrejka, Sarah L.
dc.contributor.authorAmador, Catalina
dc.contributor.authorCliment, Fina
dc.contributor.authorNg, Siok-Bian
dc.contributor.authorSoma, Lorinda
dc.contributor.authorZamo, Alberto
dc.contributor.authorDirnhofer, Stefan
dc.contributor.authorQuintanilla Martinez, Leticia
dc.contributor.authorWotherspoon, Andrew
dc.contributor.authorLeoncini, Lorenzo
dc.contributor.authorLeval, Laurence de
dc.date.accessioned2025-12-03T16:16:35Z
dc.date.available2025-12-03T16:16:35Z
dc.date.issued2023-07-27
dc.date.updated2025-12-03T10:00:29Z
dc.description.abstractFollicular helper T-cell lymphomas (TFH lymphomas) were discussed in session V of the lymphoma workshop of the European Association for Haematopathology (EA4HP)/Society for Hematopathology (SH) 2022 meeting in Florence, Italy. The session focused on the morphologic spectrum of TFH lymphoma, including its three subtypes: angioimmunoblastic-type (AITL), follicular-type, and not otherwise specified (NOS). The submitted cases encompassed classic examples of TFH lymphoma and unusual cases such as those with early or indolent presentations, associated B-cell proliferations, or Hodgkin/Reed-Sternberg-like cells. The relationship between TFH lymphoma and clonal hematopoiesis was highlighted by several cases documenting divergent evolution of myeloid neoplasm and AITL from shared clonal mutations. The distinction between TFH lymphoma and peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS), was stressed, and many challenging examples were presented. Various cases highlighted the difficulties of differentiating TFH lymphoma from other established types of lymphoma and reactive conditions. Cutaneous T-cell lymphoma expressing TFH markers, particularly when resulting in lymph node involvement, should be distinguished from TFH lymphomas. Additional immunophenotyping and next-generation sequencing studies were performed on various cases in this session, highlighting the importance of these technologies to our current understanding and classification of TFH lymphomas.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1432-2307
dc.identifier.pmid37500795
dc.identifier.urihttps://hdl.handle.net/2445/224646
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1007/s00428-023-03607-5
dc.relation.ispartofArchiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, 2023, vol. 483, 349-365
dc.relation.urihttps://doi.org/10.1007/s00428-023-03607-5
dc.rightscc-by (c) Ondrejka, Sarah L. et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationDiagnòstic immunohistoquímic
dc.subject.classificationMalalties hematològiques
dc.subject.classificationClassificació de tumors
dc.subject.otherDiagnostic immunohistochemistry
dc.subject.otherHematologic diseases
dc.subject.otherTumors classification
dc.titleFollicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
s00428-023-03607-5.pdf
Mida:
5.01 MB
Format:
Adobe Portable Document Format